Laurion Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-26,499
Closed -$2.78M 622
2022
Q2
$2.78M Buy
+26,499
New +$3.14M 0.04% 206
2020
Q4
Sell
-10,702
Closed -$1.41M 1008
2020
Q3
$1.41M Buy
10,702
+7,540
+238% +$985K 0.02% 355
2020
Q2
$366K Sell
3,162
-52,766
-94% -$6.08M ﹤0.01% 682
2020
Q1
$5.49M Buy
+55,928
New +$7.33M 0.06% 232
2019
Q4
Sell
-2,905
Closed -$387K 1287
2019
Q3
$387K Buy
+2,905
New +$375K ﹤0.01% 815
2017
Q3
Sell
-1,648
Closed -$205K 1938
2017
Q2
$205K Buy
+1,648
New +$195K ﹤0.01% 1546
2016
Q4
Sell
-105,628
Closed -$13.3M 1326
2016
Q3
$13.3M Buy
+105,628
New +$13.1M 0.13% 177
2015
Q2
Sell
-34,711
Closed -$3.96M 708
2015
Q1
$3.96M Buy
+34,711
New +$3.96M 0.08% 178
2013
Q4
Sell
-4,532
Closed -$361K 282
2013
Q3
$361K Buy
+4,532
New +$357K 0.03% 131

Other funds holding ZBH

Laurion Capital Management's ZBH Position: Q3 2022 in Review

Laurion Capital Management sold out of Zimmer Biomet (ZBH) in Q3 2022, closing a stake of 26,499 shares — an estimated $2.78M sold.

Laurion Capital Management first reported a position in ZBH in Q3 2013 and held it in 9 quarters. The position peaked at $13.3M in Q3 2016. 919 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.

  • Laurion Capital Management reported no remaining Zimmer Biomet position as of Q3 2022 after selling out during the quarter.
  • Laurion Capital Management sold 26,499 Zimmer Biomet shares in Q3 2022, an estimated $2.78M.
  • Laurion Capital Management first reported a position in Zimmer Biomet in Q3 2013 and held it in 9 quarters.
  • Laurion Capital Management's Zimmer Biomet position peaked at $13.3M in Q3 2016.
  • 919 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.

Based on Laurion Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.